Latest Financial Results
FY 2020
Fiscal Year Ended Dec 31, 2020
Stock Information
Company Overview
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders.

Investor Presentation – 38th Annual JP Morgan Healthcare Conference
Download Investor Presentation – 38th Annual JP Morgan Healthcare Conference
Investor Contact Information
Company
Natus Medical Incorporated
6701 Koll Center Parkway
Suite 120
Pleasanton, CA 94566
T: 800-645-3616
F: 650-802-0401
Investor Relations
Natus Medical Incorporated
Drew Davies
Chief Financial Officer
T: (925) 223-6700
InvestorRelations@Natus.com
Transfer Agent
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
T: (877) 830-4936
www.shareholder.broadridge.com